Tele: 561.316.3330
Breaking Medical Device News

Monday, September 27, 2021
HomeGuided Therapeutics

Guided Therapeutics

LuViva Advanced Cervical Span Awarded New CE Mark with Expanded Claims

The new CE Mark includes expanded claims for the use of LuViva by physicians for the early detection of cervical cancer.

Guided Therapeutics Inc. Receives $2.5 Million Purchase Order from Chinese Partner Shandong Medical Device Technology Company

4/2/19: Guided Therapeutics Inc. reports the purchase order includes parts for final assembly of LuViva along with single use disposables that are consumed with each LuViva test. Approximately 25% of the purchase order will be paid upon Shandong’s filing with the Chinese FDA with the remainder due once Chinese FDA approval is obtained, which is expected within about one year.

Guided Therapeutics Achieves Regulatory Approval for Sale in India

Guided Therapeutics, Inc. (OTCQB: GTHP) reported today that the Company received Regulatory Approval from the Indian Ministry of Health & Family Welfare to allow...

Guided Therapeutics Receives Order for 10 LuViva® Advanced Cervical Scans for Indonesia

Technology gaining momentum in 4th largest market Guided Therapeutics, Inc. (OTCQB: GTHP), developer of the LuViva® Advanced Cervical Scan, a non-invasive device used to detect...
spot_img

Hot Topics

By using this website you agree to accept Medical Device News Magazine Privacy Policy